These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36540013)

  • 1. Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    Suzuki M; Koshikawa S; Watanabe H; Inomata N; Yamaguchi Y; Aihara M; Sueki H
    J Dermatol; 2023 Apr; 50(4):536-540. PubMed ID: 36540013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
    Miyagawa F; Asada H
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
    Miyagawa F; Hasegawa A; Imoto K; Ogawa K; Kobayashi N; Ito K; Fujita H; Aihara M; Watanabe H; Sueki H; Tohyama M; Asada H
    Eur J Dermatol; 2015; 25(1):87-9. PubMed ID: 25547780
    [No Abstract]   [Full Text] [Related]  

  • 8. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions.
    Orime M
    J Immunol Res; 2017; 2017():6928363. PubMed ID: 29226159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
    Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
    Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
    Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome.
    Ishida T; Kano Y; Mizukawa Y; Shiohara T
    Allergy; 2014 Jun; 69(6):798-805. PubMed ID: 24749495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
    Ramírez E; Bellón T; Tong HY; Borobia AM; de Abajo FJ; Lerma V; Moreno Hidalgo MA; Castañer JL; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Cachafeiro L; González-Herrada C; González O; Aramburu JA; Laosa O; Hernández R; Carcas AJ; Frías J
    Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
    Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
    Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
    Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe cutaneous drug reactions in children].
    Mockenhaupt M
    Hautarzt; 2017 Oct; 68(10):803-814. PubMed ID: 28932875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.
    Hanafusa T; Azukizawa H; Matsumura S; Katayama I
    J Dermatol Sci; 2012 Mar; 65(3):213-9. PubMed ID: 22226608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.